UP
ULTRAGENYX PHARMACEUTICAL, INC.
Organization · CA
Hires government relations
Biopharmaceutical Company
Who they hire
What they lobby on
Issues related to newborn screening. Extension of the Priority Review Voucher Program. H.R.9747 (PL 118-83) - Continuing Appropriations and Extensions Act, 2025
Issues relating to rare disease H. R. 7384/S. 4583 - Creating Hope Reauthorization Act.
Issues related to rare disease drug development and access; coverage for genetic testing; and newborn screening.